CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for blood cancer patients: experimental combo therapy enters phase 2 trial
Disease control Recruiting nowThis study tests a new drug combination (DZD8586 plus other medicines) in 66 adults with chronic lymphocytic leukemia or small lymphocytic lymphoma who are newly diagnosed or have not yet been treated. The goal is to see if the combination is safe and can keep the cancer from gro…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Dizal (Jiangsu) Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New drug targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a new drug called BGB-16673 for people with certain blood cancers (B-cell malignancies) that have come back or not responded to treatment. The goal is to find the best dose and see if it is safe and shrinks tumors. About 146 Chinese adults will take part in this …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
New combo trial aims to close cancer care gap for minorities
Disease control Recruiting nowThis early-stage study tests whether giving two targeted drugs together is feasible for people with certain B-cell lymphomas that have returned or stopped responding to prior therapy. The drugs, zanubrutinib and sonrotoclax, work by blocking proteins that help cancer cells surviv…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 02:01 UTC
-
New hope for blood cancer patients: experimental drug targets Tough-to-Treat CLL/SLL
Disease control Recruiting nowThis study tests a new drug called DZD8586 in adults whose chronic lymphocytic leukemia or small lymphocytic lymphoma has returned or stopped responding to previous treatments. The goal is to see if the drug can shrink or control the cancer and to understand its side effects. Abo…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for blood cancer patients: phase 3 trial launches for DZD8586
Disease control Recruiting nowThis study tests a new drug, DZD8586, against standard treatments in 250 adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that has come back or stopped responding to prior therapy. The main goal is to see if DZD8586 can delay cancer growth longer than the do…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Dizal (Jiangsu) Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Heart-Safe CLL treatment? study switches patients to acalabrutinib
Disease control Recruiting nowThis study tests whether acalabrutinib, a targeted cancer drug, can control chronic lymphocytic leukemia (CLL) without the heart side effects often caused by a similar drug, ibrutinib. About 61 adults with CLL who had heart problems on ibrutinib will switch to acalabrutinib. Rese…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Exercise may strengthen immunity in blood cancer patients
Knowledge-focused Recruiting nowThis study looks at how short-term and long-term exercise affects the immune system of people with slow-growing blood cancers like chronic lymphocytic leukemia (CLL) and indolent non-Hodgkin lymphoma (NHL). Participants will undergo fitness tests and blood draws before and after …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Heart monitor study aims to catch hidden rhythm problems in blood cancer patients
Knowledge-focused Recruiting nowThis study is for people starting a type of blood cancer medication called BTK inhibitors. Researchers want to see if a small heart monitor (implanted under the skin) can detect irregular heartbeats that these drugs might cause. The goal is to catch problems early and guide treat…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: NA • Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:38 UTC